Trade Summary

6 days ago, German Christopher Paul, serving as Corporate Controller, CAO at Rhythm Pharmaceuticals, Inc. (RYTM), sold 4,643 shares at $92.21 per share, for a total transaction value of $428,131.00.

This sale represents a 100.00% decrease in German Christopher Paul's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 4:15 PM ET, 4 days after the trade was made.

Rhythm Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.